Kronos Bio (KRON) News Today → How to Play the AI and Crypto Markets in One Swing (From Weiss Ratings) (Ad) Free KRON Stock Alerts $0.98 -0.02 (-2.00%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 2:09 AM | markets.businessinsider.comOptimistic Buy Rating for Kronos Bio Amid Positive KB-0742 Trial Progress and Expanding Oncology PipelineMay 10, 2024 | msn.comKronos Bio GAAP EPS of -$0.50 misses by $0.08, revenue of $2.52MMay 9, 2024 | msn.comKRON Stock Earnings: Kronos Bio Misses EPS, Beats Revenue for Q1 2024May 9, 2024 | globenewswire.comKronos Bio Reports First-Quarter 2024 Financial ResultsMay 7, 2024 | americanbankingnews.comKronos Bio (NASDAQ:KRON) Price Target Lowered to $2.25 at HC WainwrightMay 6, 2024 | seekingalpha.comKronos Bio: Underestimated Drug Discovery PlatformMay 5, 2024 | uk.investing.comKronos Bio shares target cut, retains buy ratingMay 4, 2024 | markets.businessinsider.comBuy Rating Affirmed for Kronos Bio Amid Promising KB-0742 Data and Solid Financial FootingMay 3, 2024 | marketbeat.comKronos Bio (NASDAQ:KRON) PT Lowered to $2.25HC Wainwright decreased their target price on shares of Kronos Bio from $2.50 to $2.25 and set a "buy" rating on the stock in a research note on Friday.April 30, 2024 | wsj.comKronos Bio Inc.April 24, 2024 | globenewswire.comKronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingApril 3, 2024 | marketbeat.comKronos Bio (NASDAQ:KRON) Stock Price Down 8%Kronos Bio (NASDAQ:KRON) Shares Down 8%March 31, 2024 | msn.com5 Boutique Fitness Studios in Bangkok for an Elevated Workout ExperienceMarch 26, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Kronos Bio (KRON), Axsome Therapeutics (AXSM) and Sotera Health (SHC)March 21, 2024 | benzinga.comRecap: Kronos Bio Q4 EarningsMarch 21, 2024 | msn.comKronos Bio reports Q4 resultsMarch 21, 2024 | investorplace.comKRON Stock Earnings: Kronos Bio Beats EPS, Beats Revenue for Q4 2023March 21, 2024 | globenewswire.comKronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial ResultsMarch 19, 2024 | seekingalpha.comKRON Kronos Bio, Inc.March 12, 2024 | marketbeat.comKronos Bio (KRON) Scheduled to Post Quarterly Earnings on WednesdayKronos Bio (NASDAQ:KRON) will be releasing earnings on Wednesday, March 13, Yahoo Finance reports.March 8, 2024 | bizjournals.comCancer drug developer Kronos Bio slashes staffing for 2nd time in 4 monthsMarch 7, 2024 | marketwatch.comKronos Bio to Cut About 21% of WorkforceMarch 7, 2024 | globenewswire.comKronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash RunwayMarch 5, 2024 | globenewswire.comKronos Bio To Present Three Posters at AACR 2024 Annual MeetingFebruary 27, 2024 | globenewswire.comKronos Bio Announces Participation in 44th Annual Cowen Health Care ConferenceFebruary 27, 2024 | finance.yahoo.comKronos Bio, Inc. (KRON)February 26, 2024 | finance.yahoo.comKRON Mar 2024 2.500 putFebruary 22, 2024 | edition.cnn.comKronos Bio IncFebruary 21, 2024 | finance.yahoo.comGroundbreaking Live Clinical Cases Completed with the Single Pass KRONOS Biopsy Closure DeviceFebruary 21, 2024 | msn.comSingle Pass’ biopsy device completes initial live clinical cases in ItalyJanuary 26, 2024 | markets.businessinsider.comBuy Rating Affirmed for Kronos Bio Amid Restructuring and Promising KB-0742 Clinical DataJanuary 25, 2024 | msn.comKronos Bio streamlines leadership, cuts CMO,CSO and COO rolesJanuary 25, 2024 | finance.yahoo.comKronos Bio Implements New Leadership Structure to Drive Pipeline AdvancementDecember 20, 2023 | finanznachrichten.deKronos Bio, Inc.: Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development CandidateDecember 19, 2023 | benzinga.comKronos Bio Stock (NASDAQ:KRON), Analyst Ratings, Price Targets, PredictionsDecember 19, 2023 | markets.businessinsider.comKronos Bio Receives Buy Rating from Analyst Amid Promising Pipeline DevelopmentsDecember 19, 2023 | markets.businessinsider.comCancer Player Kronos Bio To Stop Lanraplenib Combo Therapy Blood Cancer StudyDecember 18, 2023 | marketwatch.comKronos Bio: Data From Lanraplenib Study to Treat Type of Leukemia Doesn't Support Continuing to Phase 2December 18, 2023 | msn.comKronos ends development of larnarplenib combo therapy for AMLDecember 18, 2023 | finance.yahoo.comKronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development CandidateDecember 4, 2023 | finance.yahoo.comKronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual ConferenceNovember 28, 2023 | markets.businessinsider.comStrategic Financial Management and Promising Clinical Trials Underpin Buy Rating for Kronos BioNovember 27, 2023 | finance.yahoo.comKronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare ConferenceNovember 20, 2023 | msn.comKronos Bio CEO buys common shares worth ~$1.47MNovember 20, 2023 | finance.yahoo.comKronos Bio Up 47%, Insider Buyers Are Up 31%November 14, 2023 | finanznachrichten.deKronos Bio, Inc.: Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial ResultsNovember 14, 2023 | msn.comKronos Bio GAAP EPS of -$0.54 misses by $0.03, revenue of $0.92M misses by $0.48MNovember 13, 2023 | finance.yahoo.comKronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial ResultsNovember 5, 2023 | morningstar.comKronos Bio Inc Ordinary Shares KRONNovember 2, 2023 | marketwatch.comKronos Bio to Cut 19% of Workforce in Bid to Extend Runway Get Kronos Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRON and its competitors with MarketBeat's FREE daily newsletter. Email Address Wall Street legend who predicted 2021 tech crash issues new warning (Ad)People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history. Watch his stock warning right here, 100% free of charge KRON Media Mentions By Week KRON Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRON News Sentiment▼-0.080.55▲Average Medical News Sentiment KRON News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRON Articles This Week▼61▲KRON Articles Average Week Get Kronos Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EQ News Today ALRN News Today CARM News Today EGRX News Today MURA News Today KZR News Today MNOV News Today CKPT News Today AEON News Today VHAQ News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRON) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings"The Biggest Drug Ever" Is ComingBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kronos Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
